Sarcopenia in Cirrhosis: Fallout on Liver Transplantation

被引:43
|
作者
Kumar, Vaibhaw [1 ]
Benjamin, Jaya [2 ]
Shasthry, Varsha [2 ]
Bharathy, Kishore G. Subramanya [1 ]
Sinha, Piyush K. [1 ]
Kumar, Guresh [3 ]
Pamecha, Viniyendra [1 ]
机构
[1] Inst Liver & Biliary Sci, Dept Hepato Pancreato Biliary & Liver Transplant, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Clin Nutr, New Delhi, India
[3] Inst Liver & Biliary Sci, Dept Clin Res, New Delhi, India
关键词
nutritional status; asian indian; chronic liver disease; skeletal muscle area; liver transplant outcome; SKELETAL-MUSCLE MASS; WHOLE-BODY; IMPACT; OUTCOMES; COMPLICATIONS; SURVIVAL; COHORT; INDEX;
D O I
10.1016/j.jceh.2019.12.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Liver transplantation (LT) is a game changer in cirrhosis. Poor muscle mass defined as sarcopenia may potentially upset the LT scoreboard. Aim: To assess the prevalence and impact of sarcopenia on the intraoperative and early postoperative outcomes in Indian patients undergoing LT. Methods: Pre LT, single-slice routine computed tomography images at L3 vertebra of 115 LT recipients were analyzed, to obtain cross-sectional area of six skeletal muscles normalized for height in m(2) - skeletal muscle index (SMI; cm(2)/m(2)). SMI < 52.4 in males and <38.5 in females was called sarcopenia. The intraoperative, postoperative outcome parameters and 90-day mortality were compared between sarcopenics and nonsarcopenics. Results: Sarcopenia was found in 47.8% of patients [M (90.4%); age, 46.3 +/- 10; BMI, 24.5 +/- 4.3 kg/m2; child A:B:C = 1%:22%:77%; MELD, 20.6 +/- 6.3; etiology alcohol: nonalchohol = 53%:47%; Charlson Comorbidity Index (CCI) > 3:<= 3 = 56.5%:43.5%]. Sarcopenics vs. Nonsarcopenics; early postoperative complications: [sepsis, 49(89%) vs. 33(55%), P = 0.001; neurologic complications, 16(29.6%) vs. 5(8.8%), P = 0.040; Clavien-Dindo Classification 3-24 (43.6%):15 (25.4%),P = 0.041; ancillary parameters (days), duration of ventilation [median (range)] 1.5(1-3) vs. 1 (1-2), P = 0.021; intensive care unit (ICU) stay 12 (8-16) vs. 10 (8-12), P = 0.024; time to ambulation 9 (7-11) vs. 6 (5-7), P = 0.001; drain removal 18.7 +/- 7.3 vs. 14.4 +/- 6.2, P = 0.001; need for tracheostomy 5 (9%) vs. 0 (%), P = 0.017; preoperative prevalence of acute kidney injury, comorbidities and requirement for dialysis, intraoperative blood loss & inotropic support were significantly higher in sarcopenics. Ninety-day mortality was comparable between sarcopenics 5 (9.09%) and nonsarcopenics 4 (6.6%) P = 0.63. SMI (OR: 0.83; 95% CI: 0.71-0.97, P = 0.016; Acute on chronic liver failure (ACLF) presentation 12.5 (1.65-95.2), P = 0.015 and intraoperative blood loss 3.74 (0.96-14.6), P = 0.046 were predictors of 90-day mortality. Conclusion: Almost 50% of LT recipients had sarcopenia, who had a higher incidence of postoperative sepsis, neurological complications, longer ICU stay and ventilatory support. Low SMI, ACLF presentation, and intraoperative blood loss were the independent predictors of early mortality.
引用
收藏
页码:467 / 476
页数:10
相关论文
共 50 条
  • [21] Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
    Nishikawa, Hiroki
    Enomoto, Hirayuki
    Nishiguchi, Shuhei
    Iijima, Hiroko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 24
  • [22] Testosterone treatment for patients with sarcopenia and liver cirrhosis
    Schlevogt, Bernhard
    Heinzow, H. S.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (06): : 594 - 595
  • [23] Sarcopenia impairs prognosis of patients with liver cirrhosis
    Hanai, Tatsunori
    Shiraki, Makoto
    Nishimura, Kayoko
    Ohnishi, Sachiyo
    Imai, Kenji
    Suetsugu, Atsushi
    Takai, Koji
    Shimizu, Masahito
    Moriwaki, Hisataka
    NUTRITION, 2015, 31 (01) : 193 - 199
  • [24] Sarcopenia as a prognostic marker in patient with liver cirrhosis
    Varshney, Tarun
    Sidhu, Sandeep S.
    Saggar, Kavita
    Kashyap, Harsh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 121 - 121
  • [25] The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation
    D'Arcangelo, Francesca
    Zanetto, Alberto
    Aliberti, Camillo
    Shalaby, Sarah
    Pellone, Monica
    Sciarrone, Salvatore Stefano
    Becchetti, Chiara
    Ferrarese, Alberto
    Gambato, Martina
    Russo, Francesco Paolo
    Germani, Giacomo
    Senzolo, Marco
    Vitale, Alessandro
    Cillo, Umberto
    Burra, Patrizia
    HEPATOMA RESEARCH, 2021, 7
  • [26] Sarcopenia in children awaiting liver transplantation
    Lurz, Eberhard
    Patel, Hiten
    Kamath, Binita M.
    Govind, Chavan
    Wales, Paul
    Ng, Vicky L.
    HEPATOLOGY, 2016, 64 : 698A - 698A
  • [27] Sarcopenia and Mortality after Liver Transplantation
    Englesbe, Michael J.
    Patel, Shaun P.
    He, Kevin
    Lynch, Raymond J.
    Schaubel, Douglas E.
    Harbaugh, Calista
    Holcombe, Sven A.
    Wang, Stewart C.
    Segev, Dorry L.
    Sonnenday, Christopher J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (02) : 271 - 278
  • [28] Assessment and significance of sarcopenia in liver transplantation
    Nguyen Hai Nam
    Kaido, Toshimi
    Uemoto, Shinji
    CLINICAL TRANSPLANTATION, 2019, 33 (12)
  • [29] Sarcopenia and Survival After Liver Transplantation
    Clark, Katie
    Cross, T. J. S.
    LIVER TRANSPLANTATION, 2014, 20 (11) : 1423 - 1423
  • [30] Anthropometric measures associated with sarcopenia in outpatients with liver cirrhosis
    Santos, Livia A. A.
    Lima, Talles B.
    do Val Ietsugu, Marjorie
    de Carvalho Nunes, Helio R.
    Qi, Xingshun
    Romeiro, Fernando G.
    NUTRITION & DIETETICS, 2019, 76 (05) : 613 - 619